This title has not complied with editorial timelines, so it has been withdrawn by the Managing Editor. However, a new team are going to develop a new protocol, with up‐to‐date methodology, on this subject, as part of a NIHR‐funded programme to systematically review existing evidence on topical corticosteroid safety in atopic eczema. Most of the authors on the original protocol will remain on the new team.